Merck & Co.

Merck confirms diabetes retreat

Merck confirms diabetes retreat

By Kirsty Barnes

Merck Serono intends to forge ahead with severing its investment in
diabetes and either sell or partner out its existing research and
development (R&D) activities in this field, which it no longer
feels able to compete in effectively.

People on the move

People on the move reports its periodic round-up of new
appointments in the pharmaceutical sector, headlined this week by
the appointment of a new head of manufacturing at US drugmaker
Merck & Co.


Follow us


View more


Featured Suppliers